EVERSANA’s oncology and hematology experts will be on-site at the 66th ASH Annual Meeting, the premier event in classical and malignant hematology.
Click here to schedule a meeting during the conference.
Poster Sessions
Poster #1 Title: Association between Targeted Therapy and Survival in Patients With MDS
- Session Name: 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster I
- Session Date: Saturday, December 7
- Presentation Time: 5:30 – 7:30 p.m.
- Location: San Diego Convention Center, Halls G-H
- Publication Number: 1844
Poster #2 Title: Association between Targeted Therapy and Survival in Patients With AML
- Session Name: 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III
- Session Date: Monday, December 9
- Presentation Time: 6:00 – 8:00 p.m.
- Location: San Diego Convention Center, Halls G-H
- Publication Number: 4238
About EVERSANA ONCOLOGY Commercialization™
EVERSANA ONCOLOGY Commercialization™ is the optimal solution for oncology drug manufacturers. With this innovative model, our partners optimize their investments, minimize risk and increase speed to market.
Our highly adaptable model is tailored to meet the specific needs of smaller or targeted patient populations within particular indications. It is built to navigate the challenges posed by competition, evolving patient journeys and regulatory changes from the FDA. With a focus on hem/oncology, this commercialization framework offers agility and data-driven strategies, and is designed to support the rapidly changing drug pipeline in these therapeutic areas. The model’s flexibility allows for the customization of strategies and the development of specialized functional service areas.
By providing all commercial services under one roof, the model ensures high visibility and connectivity between services, optimizing cost management and eliminating the need for additional infrastructure investments.
View Our Latest Thought Leadership
Learn how to drive greater impact in your oncology product launch. Read the latest articles from our experts.